207 related articles for article (PubMed ID: 38393490)
1. The role and regulation of SIRT1 in pulmonary fibrosis.
Ma X; Jiang M; Ji W; Yu M; Tang C; Tian K; Gao Z; Su L; Tang J; Zhao X
Mol Biol Rep; 2024 Feb; 51(1):338. PubMed ID: 38393490
[TBL] [Abstract][Full Text] [Related]
2. Sirt1 antisense long non-coding RNA attenuates pulmonary fibrosis through sirt1-mediated epithelial-mesenchymal transition.
Qian W; Cai X; Qian Q
Aging (Albany NY); 2020 Mar; 12(5):4322-4336. PubMed ID: 32139663
[TBL] [Abstract][Full Text] [Related]
3. From the Cover: l-Carnitine via PPARγ- and Sirt1-Dependent Mechanisms Attenuates Epithelial-Mesenchymal Transition and Renal Fibrosis Caused by Perfluorooctanesulfonate.
Chou HC; Wen LL; Chang CC; Lin CY; Jin L; Juan SH
Toxicol Sci; 2017 Dec; 160(2):217-229. PubMed ID: 28973641
[TBL] [Abstract][Full Text] [Related]
4. Cigarette smoke-inactivated SIRT1 promotes autophagy-dependent senescence of alveolar epithelial type 2 cells to induce pulmonary fibrosis.
Zhang Y; Huang W; Zheng Z; Wang W; Yuan Y; Hong Q; Lin J; Li X; Meng Y
Free Radic Biol Med; 2021 Apr; 166():116-127. PubMed ID: 33609723
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide phosphoribose transferase facilitates macrophage-mediated pulmonary fibrosis through the Sirt1-Smad7 pathway in mice.
Zhan T; Chen Y; Dong L; Wei T; Lu D; Wang Q; Wu Z; Xu J; Ge M
Eur J Pharmacol; 2024 Mar; 967():176355. PubMed ID: 38280463
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 as a Potential Therapeutic Target for Chronic Obstructive Pulmonary Disease.
Li S; Huang Q; He B
Lung; 2023 Apr; 201(2):201-215. PubMed ID: 36790647
[TBL] [Abstract][Full Text] [Related]
7. Salvianolic acid B attenuates epithelial-mesenchymal transition in renal fibrosis rats through activating Sirt1-mediated autophagy.
He Y; Lu R; Wu J; Pang Y; Li J; Chen J; Liu B; Zhou Y; Zhou J
Biomed Pharmacother; 2020 Aug; 128():110241. PubMed ID: 32450523
[TBL] [Abstract][Full Text] [Related]
8. Silent information regulator 1 suppresses epithelial-to-mesenchymal transition in lung cancer cells via its regulation of mitochondria status.
Zhang J; Peng J; Kong D; Wang X; Wang Z; Liu J; Yu W; Wu H; Long Z; Zhang W; Liu R; Hai C
Life Sci; 2021 Sep; 280():119716. PubMed ID: 34119539
[TBL] [Abstract][Full Text] [Related]
9. Narrower insight to SIRT1 role in cancer: A potential therapeutic target to control epithelial-mesenchymal transition in cancer cells.
Choupani J; Mansoori Derakhshan S; Bayat S; Alivand MR; Shekari Khaniani M
J Cell Physiol; 2018 Jun; 233(6):4443-4457. PubMed ID: 29194618
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide attenuates cigarette smoke-induced airway remodeling by upregulating SIRT1 signaling pathway.
Guan R; Wang J; Cai Z; Li Z; Wang L; Li Y; Xu J; Li D; Yao H; Liu W; Deng B; Lu W
Redox Biol; 2020 Jan; 28():101356. PubMed ID: 31704583
[TBL] [Abstract][Full Text] [Related]
11. Sirt1 overexpression improves senescence-associated pulmonary fibrosis induced by vitamin D deficiency through downregulating IL-11 transcription.
Zhou J; Chen H; Wang Q; Chen S; Wang R; Wang Z; Yang C; Chen A; Zhao J; Zhou Z; Mao Z; Zuo G; Miao D; Jin J
Aging Cell; 2022 Aug; 21(8):e13680. PubMed ID: 35906886
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Transforming Growth Factor-β/Smad-mediated Epithelial-Mesenchymal Transition by Celastrol Provides Protection against Bleomycin-induced Pulmonary Fibrosis.
Divya T; Velavan B; Sudhandiran G
Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):122-129. PubMed ID: 29394529
[TBL] [Abstract][Full Text] [Related]
13. SIRT1 as a therapeutic target in inflammaging of the pulmonary disease.
Rahman I; Kinnula VL; Gorbunova V; Yao H
Prev Med; 2012 May; 54 Suppl(Suppl):S20-8. PubMed ID: 22178470
[TBL] [Abstract][Full Text] [Related]
14. Bryodulcosigenin attenuates bleomycin-induced pulmonary fibrosis via inhibiting AMPK-mediated mesenchymal epithelial transition and oxidative stress.
Ding Y; Wang L; Liu B; Ren G; Okubo R; Yu J; Zhang C
Phytother Res; 2022 Oct; 36(10):3911-3923. PubMed ID: 35794782
[TBL] [Abstract][Full Text] [Related]
15. miR-133b and miR-199b knockdown attenuate TGF-β1-induced epithelial to mesenchymal transition and renal fibrosis by targeting SIRT1 in diabetic nephropathy.
Sun Z; Ma Y; Chen F; Wang S; Chen B; Shi J
Eur J Pharmacol; 2018 Oct; 837():96-104. PubMed ID: 30125566
[TBL] [Abstract][Full Text] [Related]
16. Sirtuin 1: A Target for Kidney Diseases.
Kong L; Wu H; Zhou W; Luo M; Tan Y; Miao L; Cai L
Mol Med; 2015 Jan; 21(1):87-97. PubMed ID: 25587857
[TBL] [Abstract][Full Text] [Related]
17. SIRT1 induces epithelial-mesenchymal transition by promoting autophagic degradation of E-cadherin in melanoma cells.
Sun T; Jiao L; Wang Y; Yu Y; Ming L
Cell Death Dis; 2018 Jan; 9(2):136. PubMed ID: 29374154
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.
Cha BK; Kim YS; Hwang KE; Cho KH; Oh SH; Kim BR; Jun HY; Yoon KH; Jeong ET; Kim HR
Oncotarget; 2016 Aug; 7(35):57213-57227. PubMed ID: 27528025
[TBL] [Abstract][Full Text] [Related]
19. SIRT1 suppresses the epithelial-to-mesenchymal transition in cancer metastasis and organ fibrosis.
Simic P; Williams EO; Bell EL; Gong JJ; Bonkowski M; Guarente L
Cell Rep; 2013 Apr; 3(4):1175-86. PubMed ID: 23583181
[TBL] [Abstract][Full Text] [Related]
20. Targeting anti-aging protein sirtuin (Sirt) in the diagnosis of idiopathic pulmonary fibrosis.
Shaikh SB; Prabhu A; Bhandary YP
J Cell Biochem; 2019 May; 120(5):6878-6885. PubMed ID: 30390331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
